JPM
JPMorgan Chase & Co.
JPM has the edge over NRDS overall, supported by stronger modeled upside and lower modeled downside.
NRDS
NerdWallet, Inc.
NRDS offers stronger valuation, but that advantage does not outweigh its weaker overall profile.
JPM Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
JPM's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like JPM.
NRDS Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| N/A | |
| N/A |
NRDS's revenue and profitability are currently stable. Free cash flow and net leverage aren't meaningful measures for financial services companies like NRDS.
JPM PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.7x | $231 | -33% |
| Fair | 12x | $287 | -16% |
| Current | 14x | $343 | — |
| Forward | 14x | $343 | — |
| Expensive | 15x | $361 | +5.2% |
Historical ranges are pointers, not guarantees.
JPM's PE is in its expensive range at 14.4x. If earnings grow as analysts expect, today's price would be 13.7x next year's earnings.
NRDS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 9.4x | $7.31 | — |
| Cheap | 11x | $8.58 | +17% |
| Forward | 11x | $7.31 | — |
| Fair | 19x | $14.91 | +104% |
| Expensive | 246x | $192 | +2522% |
Historical ranges are pointers, not guarantees.
NRDS has the edge over JPM in the historical PE scenario, which offers more potential upside but is not a forecast.
JPM Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
JPM has the edge over NRDS on the outlook, with more favorable valuation and earnings expectations.
NRDS Forward outlook
| Metric | Outlook |
|---|---|
| Deteriorating | |
| Strong decline | |
| Stable | |
| Strongly weakening | |
| Limited | |
| Low |
Analysts expect NRDS's earnings and profitability to decline, with its revenue holding steady. However, they disagree widely on these estimates.
JPM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $24.99 | +4.8% |
| Q3 2026 | $23.85 | +18% |
| Q2 2026 | $23.35 | +20% |
| Q1 2026 | $20.89 | +2.5% |
| Q4 2025 | $20.02 | +1.4% |
| Q3 2025 | $20.20 | +12% |
| Q2 2025 | $19.50 | +8.7% |
| Q1 2025 | $20.38 | +23% |
| Q4 2024 | $19.75 | +22% |
JPM has the edge over NRDS on earnings, with more consistent year-over-year improvement.
NRDS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.67 | -15% |
| Q3 2026 | $0.78 | -17% |
| Q2 2026 | $0.89 | +48% |
| Q1 2026 | $0.93 | +151% |
| Q4 2025 | $0.64 | +68% |
| Q3 2025 | $0.94 | +$1.07 |
| Q2 2025 | $0.60 | +$0.74 |
| Q1 2025 | $0.37 | +$0.53 |
| Q4 2024 | $0.38 | +$0.53 |
NRDS earned $0.78 per share over the past year, down 17% from the year before.
JPM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $50.2B | +8.1% |
| Q2 2026 | $57.3B | +28% |
| Q1 2026 | $49.8B | +10% |
| Q4 2025 | $45.8B | +7.1% |
| Q3 2025 | $46.4B | +8.8% |
| Q2 2025 | $44.9B | -11% |
| Q1 2025 | $45.3B | +8.1% |
| Q4 2024 | $42.8B | +11% |
JPM's revenue has grown year over year for five quarters in a row: $50.2B last quarter, up 8.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 40% | -0.2 points |
| Q2 2026 | 48% | +7.3 points |
| Q1 2026 | 41% | +0.5 points |
| Q4 2025 | 37% | -3.2 points |
| Q3 2025 | 40% | +0.6 points |
| Q2 2025 | 41% | -6 points |
| Q1 2025 | 41% | -0.6 points |
| Q4 2024 | 41% | +11 points |
JPM has the edge over NRDS on profitability, with a higher operating margin.
NRDS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $239.6M | +11% |
| Q2 2026 | $197.3M | +5.6% |
| Q1 2026 | $222.2M | +6.2% |
| Q4 2025 | $225.4M | +23% |
| Q3 2025 | $215.1M | +12% |
| Q2 2025 | $186.9M | +24% |
| Q1 2025 | $209.2M | +29% |
| Q4 2024 | $183.8M | +37% |
NRDS has the edge over JPM on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 8.1% | -7.9 points |
| Q2 2026 | 3.5% | -2.2 points |
| Q1 2026 | 12% | +12 points |
| Q4 2025 | 8.6% | +3.9 points |
| Q3 2025 | 16% | +13 points |
| Q2 2025 | 5.7% | +12 points |
| Q1 2025 | 0.3% | -2 points |
| Q4 2024 | 4.7% | +1.3 points |
NRDS's operating margin was 8.1% last quarter, down 7.9 points from the same quarter a year ago.
JPM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $33.2B | +$78.4B |
| Q2 2026 | -$25.3B | -186% |
| Q1 2026 | -$211.8B | +$40.1B |
| Q4 2025 | $119.7B | -19% |
| Q3 2025 | -$45.2B | +$28.9B |
| Q2 2025 | $29.5B | -23% |
| Q1 2025 | -$251.8B | -$97.7B |
| Q4 2024 | $147.8B | +145% |
JPM's free cash flow was −$84.2B over the past year, against −$120B the year before. Free cash flow isn't a meaningful measure for financial services companies like JPM.
NRDS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $31M | -36% |
| Q2 2026 | $41.1M | +145% |
| Q1 2026 | $35.3M | +33% |
| Q4 2025 | $38.6M | +298% |
| Q3 2025 | $48.4M | +67% |
| Q2 2025 | $16.8M | +70% |
| Q1 2025 | $26.5M | +17% |
| Q4 2024 | $9.7M | -67% |
NRDS has the edge over JPM on cash generation, producing positive trailing cash flow while its opponent burns cash.
JPM Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -11.2M shares |
| 1 year | -3.1% | -84.6M shares |
| 3 years | -8.5% | -249M shares |
| 5 years | -11% | -322M shares |
| Available history | -17% | -547M shares |
JPM has 2.7B diluted shares, down 3.1% from a year ago, with $24.5B in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.1B |
| Q2 2026 | $6.8B |
| Q1 2026 | $8.3B |
| Q4 2025 | $8.3B |
| Q3 2025 | $8.3B |
| Q2 2025 | $7.5B |
| Q1 2025 | $7.5B |
| Q4 2024 | $4.3B |
JPM spent $24.5B buying back its own shares over the past year, down 11% from the year before.
NRDS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1.7% | -1.1M shares |
| 1 year | -16% | -12.2M shares |
| 3 years | -17% | -12.8M shares |
| 5 years | -0.1% | -47.3K shares |
| Available history | +17% | +9.6M shares |
NRDS has the edge over JPM on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $10.5M |
| Q2 2026 | $22.8M |
| Q1 2026 | $66M |
| Q4 2025 | $50.7M |
| Q3 2025 | $19.2M |
| Q3 2024 | $68.7M |
| Q3 2023 | $10.8M |
| Q4 2021 | — |
NRDS spent $150M buying back its own shares over the past year.
JPM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.5x | Very low |
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.6x | Very low |
| Q4 2025 | 0.5x | Very low |
| Q3 2025 | 0.6x | Very low |
| Q2 2025 | 0.5x | Very low |
| Q1 2025 | 0.5x | Very low |
| Q4 2024 | 0.4x | Very low |
JPM's net debt is less than a year of its operating earnings (EBITDA). Net leverage isn't a meaningful measure for financial services companies like JPM.
NRDS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.7x | Net Cash |
| Q2 2026 | -0.5x | Net Cash |
| Q1 2026 | -0.4x | Net Cash |
| Q4 2025 | -0.8x | Net Cash |
| Q3 2025 | -1.2x | Net Cash |
| Q2 2025 | -1.4x | Net Cash |
| Q1 2025 | -1.7x | Net Cash |
| Q4 2024 | -1.1x | Net Cash |
NRDS has the edge over JPM on leverage, with a lower net debt burden relative to earnings.
JPM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.8 | Neutral |
| Stochastic | 31.5 | Neutral |
JPM's weekly RSI is 55 (neutral) and its Stochastic is 31 (neutral).
NRDS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 36.8 | Neutral |
| Stochastic | 31.1 | Neutral |
NRDS's weekly RSI is 37 (neutral) and its Stochastic is 31 (neutral).
JPM PE vs Financial Services Sector
| Metric | JPM | Sector median | Relative |
|---|---|---|---|
| PE | 14x | 13x | 10% above |
| PE % | 76 | 63 | 13 pts above |
JPM is trading at 14x earnings, a 10% premium to the Financial Services sector's median of 13x.
NRDS PE vs Financial Services Sector
| Metric | NRDS | Sector median | Relative |
|---|---|---|---|
| PE | 9.4x | 13x | 28% below |
| PE % | 5 | 64 | 59 pts below |
NRDS has the edge over JPM on valuation relative to its sector.
JPM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $336.8 | 1.8% above |
| 20 week MA | $345.3 | 0.7% below |
| 50 week MA | $323.2 | 6.1% above |
| 100 week MA | $298.9 | 15% above |
| 200 week MA | $236.6 | 45% above |
JPM has the edge over NRDS on trend strength, trading above more of its moving averages.
NRDS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $9.28 | 21% below |
| 20 week MA | $9.41 | 22% below |
| 50 week MA | $10.3 | 29% below |
| 100 week MA | $10.8 | 32% below |
| 200 week MA | $11.8 | 38% below |
NRDS is in a downtrend: it's below all five of its weekly moving averages, and 38% below its 200-week average.
JPM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $139.1 | $124.5 | -11% |
| 2021 | $124.5 | $157.3 | +26% |
| 2022 | $157.3 | $131.3 | -17% |
| 2023 | $131.3 | $170.1 | +30% |
| 2024 | $170.1 | $241.2 | +42% |
| 2025 | $241.2 | $327.9 | +36% |
| 2026 YTD | $327.9 | $342.8 | +4.5% |
JPM has the edge over NRDS on returns for 2026, with the stronger performance.
NRDS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $25.9 | $15.1 | -42% |
| 2022 | $15.1 | $8.99 | -41% |
| 2023 | $8.99 | $14.7 | +64% |
| 2024 | $14.7 | $13.2 | -11% |
| 2025 | $13.2 | $13.9 | +5.8% |
| 2026 YTD | $13.9 | $7.31 | -48% |
NRDS has finished lower in three of the last five years. It's down 48% so far in 2026.